Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies

(2020) Katie M. Leick et al.   ANNALS OF SURGICAL ONCOLOGY

Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial

(2019) Vivian P. Bastiaenen et al.   BMC CANCER

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

(2019) Koen P. Rovers et al.   BMC CANCER

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

(2019) Koen P Rovers et al.   BMJ Open

Prospective detection of mutations in cerebrospinal fluid, pleural effusion and ascites of advanced cancer patients to guide treatment decisions

(2019) Sergio Villatoro et al.   Molecular Oncology

Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial

(2019) Nadine Leonie de Boer et al.   BMJ Open

Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival

(2018) Joel M. Baumgartner et al.   ANNALS OF SURGICAL ONCOLOGY

Application of Cell-free DNA Analysis to Cancer Treatment

(2018) Ryan B. Corcoran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study

(2016) Lieke G.E.M. Razenberg et al.   EUROPEAN JOURNAL OF CANCER

Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum

(2016) Lieselotte Lemoine et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)

(2015) Joost Huiskens et al.   BMC CANCER

Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases

(2015) Lydia G. M. van der Geest et al.   CLINICAL & EXPERIMENTAL METASTASIS

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

(2015) Leticia De Mattos-Arruda et al.   Nature Communications

Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin

(2015) T. R. van Oudheusden et al.   Scientific Reports

Patterns of metachronous metastases after curative treatment of colorectal cancer

(2014) Yvette R.B.M. van Gestel et al.   Cancer Epidemiology

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?

(2013) Diane Goéré et al.   ANNALS OF SURGERY

Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics

(2012) Csilla Hasovits et al.   CLINICAL PHARMACOKINETICS

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

(2011) Jan Franko et al.   JOURNAL OF CLINICAL ONCOLOGY